HCPCS Code J1566: Immune Globulin, Intravenous, Lyophilized, Not Otherwise Specified, 500 mg

## **HCPCS code J1566 documentation requirements** HCPCS code J1566 documentation requirements primarily include medical necessity evidence for the intravenous immune globulin (IVIG) therapy being administered. Documentation should typically include: - A detailed history and physical examination supporting the need for IVIG. - Office or progress notes that provide clinical context and rationale for the treatment. - Relevant test results with written interpretations verifying the diagnosis and indication. - Legible signatures of the physician or non-physician practitioner responsible for patient care. - Documentation aligning with Medicare Administrative Contractor (MAC) guidelines and local coverage determinations (LCDs), specifying the medical conditions approved for IVIG use. - The documentation must also meet CMS requirements for a face-to-face encounter and a written order prior to delivery (WOPD) if applicable. Complete and thorough documentation is essential to justify the use of J1566 and ensure claims are not denied for lack of medical necessity or incomplete records by Medicare or other payers.

## **J1566 billing requirements** HCPCS Code J1566 billing requirements include the following key points: - The code must be billed together with the IVIG administration service code for the same date of service. - Billing requires documentation that supports medical necessity, including diagnosis and clinical justification consistent with Medicare or payer guidelines. - If the IVIG product (J1566) and its administration are billed separately, both must appear on the claim to avoid rejection. - Providers should reference Local Coverage Determinations (LCDs), National Coverage Determinations (NCDs), and billing and coding articles published by their Medicare Administrative Contractor (MAC) for specific billing instructions. - Proper use of modifiers may be required depending on the administration route or payer instructions. - Claims processing instructions for J1566 billing are often detailed in CMS Change Requests (CRs) and related Medicare Fee-For-Service Claims Processing Manuals. - Providers may need to contact their MAC for guidance on appropriate billing practices and additional documentation requirements. These billing processes ensure that J1566 claims are correctly adjudicated and reimbursed as part of IVIG therapy administration.

## **Other relevant codes** Other relevant HCPCS codes related to J1566 (Injection, immune globulin, intravenous, lyophilized, 500 mg) include: - **J1568**: Injection, immune globulin, (Octagam), intravenous, non-lyophilized (liquid), 500 mg - **J1569**: Injection, immune globulin, (Gammagard liquid), intravenous, non-lyophilized, 500 mg - **J1561**: Injection, immune globulin, (Gamunex-C/Gammaked), intravenous, non-lyophilized, 500 mg - **J1459**: Injection, immune globulin (Privigen), intravenous, non-lyophilized, 500 mg - **J1557**: Injection, immune globulin (Gammaplex), intravenous, non-lyophilized, 500 mg - **J1572**: Injection, immune globulin (Flebogamma/Flebogamma DIF), intravenous, non-lyophilized. Usage depends on payer policies